Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
9.43
-0.18 (-1.82%)
Mar 31, 2025, 9:39 AM EDT - Market open
Evolent Health Revenue
In the year 2024, Evolent Health had annual revenue of $2.55B with 30.09% growth. Evolent Health had revenue of $646.54M in the quarter ending December 31, 2024, with 16.27% growth.
Revenue (ttm)
$2.55B
Revenue Growth
+30.09%
P/S Ratio
0.43
Revenue / Employee
$567,720
Employees
4,500
Market Cap
1.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
EVH News
- 5 weeks ago - Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Evolent Announces Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 7 weeks ago - Evolent Health Announces Changes to Board of Directors - PRNewsWire
- 2 months ago - Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - PRNewsWire
- 3 months ago - Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 - PRNewsWire
- 4 months ago - Evolent Health: A Shot At Revival After Market Bruising - Seeking Alpha
- 5 months ago - Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga